National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19 Clinical Trial Optional)

Funder: National Institutes of Health Due Date: 2/24/2020 Budget: Negotiable Opportunity: PAR-18-231 http://grants.nih.gov/grants/guide/pa-files/PAR-18-231.html The purpose of this initiative is to: accelerate innovative drug and device discovery; develop pharmacologic and neuromodulatory tools for basic and…

Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required)

Funder: National Institutes of Health Due Date: 10/15/2018 Budget: Negotiable Opportunity: RFA-MH-18-702 http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-18-702.html The purpose of this Funding Opportunity Announcement (FOA) is to support the early stage testing of pharmacologic interventions with novel mechanisms…

Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01- Clinical Trial Required)

Funder: National Institutes of Health Due Date: 10/15/2018 Budget: Negotiable Opportunity: RFA-MH-18-707 http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-18-707.html The purpose of this Funding Opportunity Announcement (FOA) is to support confirmatory efficacy testing of non-pharmacological therapeutic and preventive interventions for…